On CNBC’s “Mad Money Lightning Round,” Jim Cramer recommended waiting before buying telehealth firm Doximity, Inc. (NYSE:DOCS), noting it is “still too expensive.”
Doximity, on Nov. 6, reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 38 cents per share. The company, which connects physicians and nurse practitioners with other healthcare providers, reported quarterly sales of $168.525 million. It beat the analyst consensus estimate of $157.614 million.
Cramer recommended selling half of IREN Limited (NASDAQ:IREN) …
Full story available on Benzinga.com
On CNBC’s “Mad Money Lightning Round,” Jim Cramer recommended waiting before buying telehealth firm Doximity, Inc. (NYSE:DOCS), noting it is “still too expensive.”
Doximity, on Nov. 6, reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 38 cents per share. The company, which connects physicians and nurse practitioners with other healthcare providers, reported quarterly sales of $168.525 million. It beat the analyst consensus estimate of $157.614 million.
Cramer recommended selling half of IREN Limited (NASDAQ:IREN) …
Full story available on Benzinga.com
On CNBC’s “Mad Money Lightning Round,” Jim Cramer recommended waiting before buying telehealth firm Doximity, Inc. (NYSE:DOCS), noting it is “still too expensive.”
Doximity, on Nov. 6, reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 38 cents per share. The company, which connects physicians and nurse practitioners with other healthcare providers, reported quarterly sales of $168.525 million. It beat the analyst consensus estimate of $157.614 million.
Cramer recommended selling half of IREN Limited (NASDAQ:IREN) …Full story available on Benzinga.com Read MoreBCC, CNBC, DOCS, IREN, Long Ideas, mad money Lightning Round, News, Jim Cramer, Markets, Media, Trading Ideas, BCC, DOCS, IREN, Long Ideas, News, Markets, Media, Trading Ideas, Benzinga Markets
